Development of a Gonorrhea Vaccine Using the mRNA Platform Established at Afrigen
Time: 10:15 am
day: Day 2 Track 1 AM
Details:
- Overview of mRNA platform established in Afrigen
- Platform for sustainability with pipeline of disease targets
- Showcasing mRNA Gonorrhea vaccine as one of the pipeline targets, and early preclinical results
